Insider Trading Alert - GPK, HPQ And BCRX Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, June 9, 2015, 89 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $352.00 to $81,483,250.00.

Highlighted Stocks Traded by Insiders:

Graphic Packaging (GPK) - FREE Research Report

Yost Joseph P, who is Senior Vice President, Europe at Graphic Packaging, sold 14,000 shares at $14.06 on June 9, 2015. Following this transaction, the Senior Vice President, Europe owned 259,898 shares meaning that the stake was reduced by 5.11% with the 14,000-share transaction.

The shares most recently traded at $14.13, up $0.07, or 0.5% since the insider transaction. Historical insider transactions for Graphic Packaging go as follows:

  • 4-Week # shares bought: 12,000
  • 4-Week # shares sold: 22,500
  • 12-Week # shares bought: 12,000
  • 12-Week # shares sold: 246,963
  • 24-Week # shares bought: 12,000
  • 24-Week # shares sold: 376,963

The average volume for Graphic Packaging has been 2.6 million shares per day over the past 30 days. Graphic Packaging has a market cap of $4.6 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 2.13% year-to-date as of the close of trading on Tuesday.

Graphic Packaging Holding Company, together with its subsidiaries, provides paper-based packaging solutions to food, beverage, and other consumer products companies. The stock currently has a dividend yield of 1.44%. The company has a P/E ratio of 42.2. Currently, there are 4 analysts who rate Graphic Packaging a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on GPK - FREE

TheStreet Quant Ratings rates Graphic Packaging as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, solid stock price performance and growth in earnings per share. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Graphic Packaging Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Hewlett-Packard (HPQ) - FREE Research Report

Veghte William L, who is EVP and GM EG at Hewlett-Packard, sold 17,255 shares at $33.49 on June 9, 2015. Following this transaction, the EVP and GM EG owned 65,313 shares meaning that the stake was reduced by 20.9% with the 17,255-share transaction.

The shares most recently traded at $32.98, down $0.51, or 1.54% since the insider transaction. Historical insider transactions for Hewlett-Packard go as follows:

  • 4-Week # shares sold: 145,798
  • 12-Week # shares sold: 145,798
  • 24-Week # shares sold: 173,785

The average volume for Hewlett-Packard has been 11.2 million shares per day over the past 30 days. Hewlett-Packard has a market cap of $59.4 billion and is part of the technology sector and computer hardware industry. Shares are down 18.81% year-to-date as of the close of trading on Tuesday.

Hewlett-Packard Company, together with its subsidiaries, provides products, technologies, software, solutions, and services to individual consumers and small- and medium-sized businesses (SMBs), as well as to the government, health, and education sectors worldwide. The stock currently has a dividend yield of 2.15%. The company has a P/E ratio of 13.0. Currently, there are 10 analysts who rate Hewlett-Packard a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HPQ - FREE

TheStreet Quant Ratings rates Hewlett-Packard as a buy. Among the primary strengths of the company is its attractive valuation levels, considering its current price compared to earnings, book value and other measures. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full Hewlett-Packard Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Biocryst Pharmaceuticals (BCRX) - FREE Research Report

Staab Thomas R Ii, who is Senior Vice President and CFO at Biocryst Pharmaceuticals, sold 6,000 shares at $12.75 on June 9, 2015. Following this transaction, the Senior Vice President and CFO owned 153,144 shares meaning that the stake was reduced by 3.77% with the 6,000-share transaction.

The shares most recently traded at $12.90, up $0.15, or 1.16% since the insider transaction. Historical insider transactions for Biocryst Pharmaceuticals go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 6,000
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 18,105
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 122,899

The average volume for Biocryst Pharmaceuticals has been 872,000 shares per day over the past 30 days. Biocryst Pharmaceuticals has a market cap of $945.7 million and is part of the health care sector and drugs industry. Shares are up 7.24% year-to-date as of the close of trading on Tuesday.

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. Currently, there are 5 analysts who rate Biocryst Pharmaceuticals a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BCRX - FREE

TheStreet Quant Ratings rates Biocryst Pharmaceuticals as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share and deteriorating net income. Get the full Biocryst Pharmaceuticals Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

Check Out These 15 Stocks With Solid Dividend Yields

Check Out These 15 Stocks With Solid Dividend Yields

How to Play Rising Treasury Yields

How to Play Rising Treasury Yields

Graphic Packaging (GPK) Stock Slumps on Q3 Miss

Graphic Packaging (GPK) Stock Slumps on Q3 Miss

Graphic Packaging (GPK) Stock Gains, Q2 Results Meet Expectations

Graphic Packaging (GPK) Stock Gains, Q2 Results Meet Expectations

Barbarian At The Gate: Graphic Packaging (GPK)

Barbarian At The Gate: Graphic Packaging (GPK)